NRP1 and neoplasm: Migration of HT1080 cells along a rhodocetin-αβ gradient was concentration-dependent and could be inhibited by blocking MET, suggesting that rhodocetin-αβ induced tumor cell motility along the NRP1-MET signaling axis, similar as in ECs.